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Recent attention has focused on the emerging epidemic of cardiovascular disease in developing nations, and the 
role hypertension may play.1 While Australia 
as a nation fulfils The World Bank’s definition 
of a high income country (well surpassing 
the gross national income per head cut-off 
of US$12,476),2 significant inequality exists 
within the Australian population. Australia’s 
two Indigenous populations (Aboriginal 
people and Torres Strait Islanders) experience 
inequality related to income, education 
and health and this disparity is magnified 
for remote-living Indigenous populations. 
According to the 2008 National Aboriginal 
and Torres Strait Islander Social Survey, the 
median personal gross annual income for 
Aboriginal people and Torres Strait Islanders 
living in remote Australia was the equivalent 
of US$14,020 and 28% reported running out 
of money for basic living requirements in the 
previous 12 months.3 
Life expectancy for the Aboriginal and Torres 
Strait Islander population lies 10–11 years 
below the general Australian population.4 
The cause of this life expectancy differential 
is heterogenous and complex. A history of 
colonisation, racism and familial separation 
underpins current disadvantage and 
there are additional disparities in access to 
healthcare.4-6
Cardiovascular and renal diseases contribute 
substantially to the discrepancy in life 
expectancy with Indigenous Australians 
experiencing higher rates and at a younger 
age.4,7-9 Their precursors (hypertension, 
albuminuria, obesity and diabetes) are known 
to be common in Indigenous adults.4,10,11 
Contrasting with this picture of chronic 
disease risk in adults, Indigenous and non-
Indigenous Australian children have been 
reported to not differ in the prevalence of 
persistent chronic disease risk – in particular 
hypertension, albuminuria and obesity12,13 
– although one small study found that 36% 
of a sample of Aboriginal and Torres Strait 
Islander children aged 5–14 years attending 
for health checks in an urban setting were 
overweight or obese, a higher percentage 
than was reported for the general population 
of Queensland children aged 5–17 years 
(21.1% ).14 
The epidemiology of cardiovascular disease 
in the Australian Indigenous population has 
been rapidly evolving over recent decades 
as a consequence of major social change, 
including the shift to Western diets and more 
sedentary living.15 The prevalence of chronic 
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Abstract
Objective: Hypertension and other chronic disease risks are common among Aboriginal and 
Torres Strait Islander adults but there is little evidence regarding the epidemiology of these 
risk factors during adolescence. This study examines the prevalence of pre-hypertension, 
hypertension and other cardiovascular risk factors in Aboriginal and Torres Strait Islander 
people aged 15–24 years living in remote Indigenous communities in north Queensland. In so 
doing, it aims to better inform the approach to cardiovascular disease in this population.
Methods: This is a descriptive study that retrospectively examines health service data from 
a program of community screening, the Young Persons Check (YPC). Participants were 1,883 
Aboriginal and Torres Strait Islander people aged 15–24 years who attended for a YPC in 11 
remote communities in north Queensland between March 2009 and April 2011.
Results: Overall, the prevalence of pre-hypertension was 34.0%; stage I hypertension was 
17.7% and stage II hypertension was 3.3%. The prevalence of elevated waist circumference was 
47.6%, overweight or obesity 45.9%, elevated triglycerides 18.3%, decreased HDL 54.8% and 
proteinuria 24.3%. The prevalence of hypertension (stage I or II) among Torres Strait Islander 
males was 34.1%, Aboriginal males 26.9%, Torres Strait Islander females 12.6% and Aboriginal 
females 13.0%. Hypertension was associated with sex (males) (OR= 4.37, p<0.000), overweight 
(OR=2.46, p<0.000), obesity (OR=4.59, p<0.000) and elevated triglycerides (OR=2.38, p<0.000).
Conclusion: Pre-hypertension, hypertension and other cardiovascular risk in this population is 
highly prevalent. Hypertension was particularly prevalent among male participants. The results 
reiterate the importance of early life experience in cardiovascular disease prevention.
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diseases in remote Australian Indigenous 
populations is high;16 for example, diabetes 
prevalence in Torres Strait Islanders (>/=15 
years) is 26%17 and self-reported diabetes was 
almost twice as prevalent among remote-
living Indigenous participants in the National 
Aboriginal and Torres Strait Islander Health 
Survey.18 There is little published evidence 
regarding the onset and distribution of 
cardiovascular disease risk factors during 
Indigenous adolescence and young 
adulthood.
Pre-hypertension is described as representing 
the ‘grey zone’ between normal blood 
pressure and hypertension. A person with 
pre-hypertension is 3.5 times more likely to 
have a myocardial infarction and 1.7 times 
more likely to have coronary artery disease 
compared with someone with normal blood 
pressure.19 There are no published reports 
exploring pre-hypertension for any Aboriginal 
and Torres Strait Islander populations. 
The objective of this study was to fill an 
important evidence gap by describing the 
prevalence of hypertension and other chronic 
disease risks among remote-living Indigenous 
youth. As well as describing the prevalence of 
hypertension, pre-hypertension was explored. 
Methods
Study participants
The Young Person Check program
Between 2009 and 2012, the regional health 
authority conducted a program of health 
screening – the Young Person Check or YPC – 
targeting Aboriginal and Torres Strait Islander 
youth aged 15–24 years living in remote 
largely Indigenous communities.20 
Participants were not assessed by a doctor 
or nurse during a YPC; they were assessed 
by an Indigenous health worker from their 
own community. Assessments did not occur 
in a hospital, clinic, or research facility but 
rather in community spaces. The YPC program 
process has been reported elsewhere, 
including community consultation, 
recruitment of participants, conduct of the 
screen, participation rates and follow-up of 
abnormal findings.20 
This study was approved by the Cairns 
Base Hospital Human Research Ethics 
Committee and was conducted with support 
from the relevant Indigenous community 
organisations.
Study participants were 1,883 Aboriginal and/
or Torres Strait Islander young people aged 
15–24 years attending their first YPC in 11 
north Queensland locations between March 
2009 and April 2011. Overall, coverage of the 
15–24 year Indigenous population across all 
YPC locations between 2009 and 2012 was 
73% for females and 72% for males.
Measures
Blood pressure
Blood pressure was recorded using an Omron 
automatic blood pressure monitor with 
intellisense and the participant seated (the 
reading was taken immediately after sitting). 
If a participant had a systolic blood pressure 
>140 mmHg and/or diastolic blood pressure 
>80 mmHg a second reading was taken ten 
minutes later. The average of these two blood 
pressures was then recorded. Participants 
aged over 18 years with blood pressures 
ranging from 120–139 mmHg systolic and/
or 80–89 mmHg diastolic were defined as 
having pre-hypertension. Participants aged 
over 18 years with systolic blood pressures 
between 140 and 159 mmHg and/or diastolic 
blood pressures between 90 and 99 mmHg 
were defined as having stage l hypertension. 
Those with systolic blood pressure equal to or 
greater than 160mmHg and or diastolic equal 
to or greater than 100mgHg were defined as 
having as stage ll hypertension.19 Participants 
under 18 years were determined to have pre-
hypertension, stage I hypertension and stage 
II hypertension as delineated in the Fourth 
Report on the Diagnosis, Evaluation, and 
Treatment of High Blood Pressure in Children 
and Adolescents.21 
Body mass index (BMI)
Body weight was recorded using the same 
scales for each participant. Participants 
were asked to remove shoes and any heavy 
items from pockets. Weight was measured 
once to the nearest 0.1 kg. Height was 
measured using the same stadiometer for 
each participant. Participants were asked to 
remove shoes and hats prior to measuring 
height. Height was measured to the nearest 
0.1 cm. Body Mass Index (BMI) was defined 
as weight divided by height squared (kg/m2) 
and categorised as underweight, healthy, 
overweight and obese. For participants 
aged 15–19 years, these categories were 
based on the Center for Disease Control 
paediatric charts.22 For participants aged 
over 19 years, BMI was categorised as: 
healthy (≥18.5–25), overweight (>25–30) and 
obese (>30) according to the World Health 
Organization definition used in the local 
clinical guidelines.23
Waist circumference
Waist circumference was measured with the 
participant standing clothed with feet slightly 
apart. The tape measure was placed once 
around the narrowest part of the abdomen 
approximately half way between the hips and 
ribs. Waist was measured as the participant 
exhaled. Waist was measured to 0.1 cm. Waist 
circumference was deemed normal if it was 
<80 cm for females and <94 cm for males.23 
Plasma glucose
Blood samples were collected in the non-
fasting state. All blood samples were analysed 
at the same central laboratory. Plasma 
glucose was defined as normal if it was  
<5.5 mmol/L for males and females. Those 
with a plasma glucose of 5.5-11 mmol/L were 
classified as having an uncertain diabetic 
state and requiring further testing. Those with 
plasma glucose >11 mmol/L were classified as 
having probable diabetes.24
Plasma lipids
Non-fasting blood lipids were assessed. High 
density lipoprotein (HDL) and triglycerides 
were examined. HDL was classified as 
reduced if it was <1.0 mmol/L and the 
triglyceride level was classified as elevated if 
>2.0 mmol/L.25 
Urinalysis
A spot urine sample was collected from each 
participant and dipsticked immediately. A 
new package of urine dipsticks was used for 
each event and attention paid to temperature 
and other environmental requirements as per 
the instructions on the packaging. Proteinuria 
was defined as ≥1+ protein. Urinary albumin 
creatinine ratio (ACR) was assessed if 
proteinuria was present. ACR was defined as 
elevated if it was >2.5 mg/mmol for males 
>3.5 mg/mmol for females.26
Analysis 
Only data collected during a person’s 
first YPC visit was analysed. Data analysis 
was performed using Stata Version 12 
(Stata Corporation, Texas, USA). Univariate 
analyses were performed on the data using 
Pearson’s Chi squared test and Fischer’s 
Exact test where cell counts were less than 
five. Established risk factors and variables 
identified in univariate analysis were then 
included in forwards and backwards stepwise 
logistic regression models for hypertension. 
Logistic regression analyses were performed 
separately for those under 18 years of age and 
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those aged 18–24 years according to different 
diagnostic criteria used for hypertension. 
A significance level of p<0.05 was used. 
Proportional Venn diagrams were drawn 
using BioInfoRx software.
Results
Demographics of the YPC
Among the 1,883 participants, who were 
Indigenous and aged 15–24 years, 50.2% 
identified as Aboriginal, 34.4% as Torres 
Strait Islander and 15.4% as both Aboriginal 
and Torres Strait Islander. Males represented 
46.3% of those participating and females, 
53.7%. Pregnant women were not excluded. 
The mean age of female Aboriginal 
participants was 19.1 years, female Torres 
Strait Islander participants 18.7 years and 
female participants who identified as both 
Aboriginal and Torres Strait Islander 18.3 
years. The mean age of male Aboriginal 
participants was 18.9 years, male Torres Strait 
Islander participants 18.5 years, and male 
participants who identified as both Aboriginal 
and Torres Strait Islander 19.1 years. The mean 
age of participants overall was 18.8 years.
Among all Indigenous participants the 
prevalence of pre-hypertension was 34.0%, 
stage I hypertension was 17.7% and stage 
II hypertension was 3.3%. The prevalence 
of elevated waist circumference was 35.4%, 
overweight or obesity 46.9%, elevated 
triglycerides 18.3%, decreased HDL 54.8%, 
proteinuria 25.4% and albuminuria 6.0%.
Table 1 displays the mean values for selected 
risk factors with 95% confidence limits. 
Table 2 compares the prevalence of selected 
risk factors in male and female participants 
by ethnicity. Of those with hypertension, 
22% had proteinuria. Only 15.8% of the 
participants were free of all risk factors 
while 3.2% had all risk factors: overweight 
or obesity, increased waist circumference, 
hypertension, increased triglycerides and 
decreased HDL.
The final logistic regression model for 
those aged 18 years and over found only 
gender, overweight, obesity and elevated 
triglycerides were significantly associated 
with hypertension (Table 3). Elevated waist 
circumference and reduced HDL were 
significantly associated with hypertension 
in the univariate analysis (OR=1.98, 95%CI: 
1.42-2.76) and (OR=0.17, 95% CI: 0.15-0.20) 
respectively, but did not reach significance 
in the multivariate analysis, due in part to co-
linearity amongst the predictors.
No acceptable model could be found for 
participants aged under 18 years due to poor 
model fit.
Discussion
Pre-hypertension and hypertension were 
highly prevalent in this sample of Indigenous 
youth, particularly among males (Table 
2). The mean systolic blood pressure for 
males of both ethnicities fulfils the criteria 
for pre-hypertension (Table 1). In addition, 
overweight and obesity were highly prevalent 
and associated with hypertension among 
Indigenous males and females aged 18–24 
years. 
In 2011-12 the Australian Health Survey found 
that 31.6% of all Australians aged over 18 
years and 6.0% of those aged 18–24 years had 
hypertension.27 In the same survey, 60.0% of 
men and 66.6% of women over 18 years had 
a waist circumference that put them at risk. 
The Australian Aboriginal and Torres Strait 
Islander Health Survey found that 20.4% of 
Indigenous adults had hypertension. It also 
found that 66% of Indigenous Australians 
aged 15 years and over were overweight 
(28.6%) or obese (37.4%).28 The results of 
our study contrast with the prevalence of 
hypertension measured among the general 
Queensland population aged 18–24 years 
(7.5%)29 and among Native American youth 
in the Strong Heart Study30 where the 
prevalence among women aged 20–24 years 
was 6.2% and among men was 16.4%. The 
hypertension prevalence among a sample of 
remote-living north Queensland Aboriginal 
and Torres Strait Islander adults in 2005 was 
33.2%, only marginally higher than the overall 
prevalence of hypertension (that is, 21% had 
Stage I or II) found in this adolescent sample.31 
Cardiovascular disease risk data from the 
general Queensland population provides 
some further insight. Based on self-report, 
38.3% of Queensland males and 31.4% 
of Queensland females aged 18–24 are 
overweight or obese32 and 6.6% of the adult 
Australian population over 25 years have 
albuminuria.33 The overall prevalence of 
overweight or obesity (46.9%), hypertension 
(21.0%) and albuminuria (6.0%) in this 
remote and younger population suggest 
that Indigenous youth are experiencing a 
heavy burden of cardiovascular disease risk. 
The prevalence of probable diabetes was 
low when compared with other risk factors 
in this sample. Evidence suggests, however, 
that renal impairment and hypertension 
are the earliest overt signs of the metabolic 
syndrome in Indigenous Australians.34 This 
Table 1: Mean values, with 95% confidence limits of select chronic disease risk factors by gender and ethnicity in Indigenous participants aged 15–24 years.
Chronic Disease Risk Factor Gender Aboriginal Mixed Indigenous Heritage Torres Strait Islander
Systolic blood pressure (mmHg) Females
Males
115.5 (114.4–116.6) n=517
127.5 (126.2–128.7) n= 427
116.1 (114.1–118.1) n=161
129 (126.5–131.5) n=129
114.8 (113.4–116.1) n=332
128.1 (127.0–130.2) n=315
Diastolic blood pressure (mmHg) Females
Males
72.5 (71.6–73.3) n=517
73.2 (72.3–74.2) n=427
72.4 (70.9–73.9) n=161
75.3  (73.5–77.0) n=129
73.9 (72.8–74.9) n=332
75.8 (74.6–76.9) n=315
BSL (mmol/L) Females
Males
5.0 (4.9–5.1) n=502
5.1 (5.0–5.1) n=426
5.3 (4.9–5.6) n=153
5.0 (4.8–5.2) n=116
5.3(5.0–5.6) n=329
5.0 (4.9–5.2) n=309
Waist Circumference (cm) Females
Males
85.3 (81.9–88.7) n=517
82.6 (81.3–84.0) n=427
96.9 (85.5–109.4) n=158 
91.9 (88.7–95.1) n=128
93.3 (91.7–95.0) n=326 
92.6 (90.8–94.5) n=315
BMI (kg/m2) Females
Males
22.8 (22.2–23.4) n=479
22.2 (21.7–22.7) n=401
26.8 (25.7–27.9) n=122
264 (25.0–27.7) n=94
27.2 (26.4–27.9) n=322
 26.9 (26.2–27.7) n=309
HDL (mmol/L) Females
Males
0.9 (0.9–1.0) n=504
0.9 (0.8–0.9) n=427
1.0 (1.0–1.0) n=160
1.0  (0.9–1.0) n=127
1.0 (1.0–1.2) n=329
1.1 (1.0–1.1) n=314
Triglycerides (mmol/L) Females
Males
1.6 (1.2–1.4) n=504
1.6  (1.5–1.7) n=427 
1.7 (1.2–1.5) n=160
1.7 (1.5–1.9) n=127
1.6 (1.3–1.5) n=329
1.6 (1.5–1.7)  n=314 
n is number of participants that had that test.
95% confidence intervals in brackets.
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Table 2:  Selected chronic disease risk factor prevalence in Aboriginal and Torres Strait Islander participants aged 15–24 years.
Variable Aboriginal females 
(percentage)
Mixed Indigenous 
heritage  females 
(percentage)
Torres Strait Islander 
females (percentage)
p 
value
Aboriginal males 
(percentage)
Mixed Indigenous 
heritage males 
(percentage)
Torres Strait Islander 
males (percentage)
p 
value
Pre–hypertension 26.6 (22.7–30.5) n=517 28.6 (21.1–36.1) n=161 24.3 (19.6–29.0) n=332 0.594 42.7 (37.9–47.5) n=427 50.4 (41.2–59.6) n=129 41.2 (35.7–46.8) n=315 0.226
Hypertension (Stage I or Stage 
II hypertension)
13.0 (10.0–16.0) n=517 17.9 (11.5–24.2) n=161 12.6 (9.0–16.2) n=332 0.274 26.9 (22.6–31.2) n=427 26.1 (18.0–34.2) n=129 34 (28.8–39.4) n=315 0.079
Stage II hypertension 1.8 (0.6–3.0) n=517 1.4 (–0.5–3.4) n=161 2.5 (0.8–4.2) n=332 0.769 4.7 (2.6–6.8) n=427 4.4 (0.6–8.1) n=129 4.9 (2.5–7.3) n=315 0.975
Uncertain diabetic state. BSL 
5.5–11.0 mmol/L
19.3 (0.16–0.23) n=502 25.5 (15.9–22.8) n=153 21.3 (16.8–25.7) n=329 0.255 28.2 (23.9–32.5) n=426 24.1 (0.16–0.32) n=116 22.7 (17.7–27.0) n=309 0.188
Probable diabetes. 
BSL>11.1mmol/L
0.6 (0.1–1.3) n=502 0.1 (0–0.3) n=153 1.5 (0.2–2.8) n=329 0.400 0 n=426 0 n=116 0.3 (0.0–0.9) n=309 0.416
Elevated waist circumference 52.4 (48.1–56.7) n=517 72.2 (65.1–79.2) n=158 78.8 (74.4–83.3) n=326 0.000 19.2 (15.5–23.0) n=427 35.2 (26.8–43.5) n=128 38.4 (33.0–43.8) n=315 0.000
BMI overweight or obese 33.2 (29.0–37.4) n=479 64.8 (56.2–73.3) n=122 64.3 (59.0–69.5) n=322 0.000 28.2 (23.8–32.6) n=401 51.1 (40.9–61.3) n=122 60.5 (55.0–66.0) n=309 0.000
BMI Obese 16.9 (13.5–20.3) n=479 37.3 (29.1–46.4) n=122 37.7 (32.0–42.6) n=322 0.000 11.2 (8.1–14.3) n=401 24.5 (15.7–33.2) n=122 32.7 (27.4–37.9) n=309 0.000
Triglycerides >2.0 mmol/L 14.1 (11.0–17.1) n=504 14.4 (9.0–19.8) n=160 15.5 (11.6–19.4) n=329 0.849 19.7 (15.9–23.5) n=427 21.3(14.1–28.4) n=127 26.8 (21.8–31.7) n=314 0.070
HDL <1.0 mmol/L 61.3 (57.0–65.6) n=504 52.5 (44.7–60.3)  n=160 44.1 (38.7–49.5) n=329 0.000 66.3 (61.8–70.8) n=427 52.8 (44.0–61.5) n=127 41.7 (36.2–47.2) n=314 0.000
Proteinuria 32.8 (28.8–36.9) n=518 21.7 (15.3–28.1) n=161 13.5 (9.8–17.2) n=333 0.000 28.3 (18.0–32.6) n=427 25.8 (18.0–33.2) n=129 17.1 (13.0–21.3) n=315 0.002
Proportion of those with 
proteinuria that demonstrated 
albuminuria* >3.5 mg/mol 
females >2.5 mg/mmol males
34.3 (26.4–42.1) 33.3 (15.1–51.6) 31.7 (17.2–46.2) NA 10.6 (4.3–17.5) 36.0 (16.7–55.3) 35.3 (22.0–48.6) NA
**Minimum albuminuria 
prevalence
9.5 5.6 3.9 NA 2.3 7.0 5.7 NA
n is number of participants that had that test.
95% confidence intervals in brackets.
*ACR was only evaluated on participants who had a positive urine dipstick test (≥1+ protein).   
**These represent a minimum albuminuria prevalence due to the method of selection for ACR testing.  
Table 3: Final model of independent associations 
with hypertension in participants aged 18-24 years.
Adjusted Odds ratio*   
(95% confidence interval)
p value
Sex (Male) 4.37 (2.92- 6.54) <0.000
Overweighta 2.46 (1.53 – 3.97) <0.000
Obesitya 4.59 (2.87 – 7.36) <0.000
 Triglycerides 2.38 (1.61 – 3.52) <0.000
* Adjusted for all variables for which an estimate is shown
a: as compared with normal/underweight participants
is supported by the recognition that the 
prevalence of diabetes increases rapidly 
in Indigenous populations after the age of 
35 years.35-37 We are limited in our ability to 
compare these results with other Indigenous 
community surveys that have focused on the 
broader adult population, as coverage among 
adolescents and young adults has been low 
and they have used either a fasting measure 
of BSL or glucose tolerance test (GTT). 
Limitations
The possible impact of ‘white coat’ 
hypertension on the results presented here 
is unclear; however, the interaction between 
health staff and YPC participants was youth 
friendly, culturally appropriate, occurred 
outside of the clinic and excluded the taking 
of a medical history. This context is likely to 
have produced less ‘white coat hypertension’ 
than a traditional western medical setting. 
While the study may be criticised for relying 
on a single measure (or two, if the initial 
result was elevated) of blood pressure as 
not complying with traditional research 
methodology, it must be remembered that 
these data result from a service delivery 
program. Among the Indigenous population, 
this age group has traditionally been reticent 
to participate in research studies, making 
the findings described here particularly 
pertinent. While at a clinical level the 
method of BP assessment does not allow 
for reliable categorising of hypertension, it 
provides useful population level information, 
particularly in view of the high participation 
number.
While traditionally lipid profiles are assessed 
in the fasting state, there is growing evidence 
that non-fasting lipids are as acceptable a 
measure.38,39 Similarly, there has been debate 
about whether different cut-offs for waist 
circumference are necessary for Aboriginal 
versus Torres Strait Islander people.40 
Given the age of these participants and 
the substantial proportion of our sample 
identifying as both Aboriginal and Torres 
Strait Islander, the same thresholds were 
applied across all ethnicities. 
Problems with the utility of proteinuria as a 
screening test for renal disease have been 
identified41 although Hoy et al. report it to 
be reasonably robust.42 The prevalence of 
albuminuria, representing – as it does here – a 
minimum prevalence, suggests that the risk 
of renal disease is high in both Aboriginal and 
Torres Strait Islander young people.
Strengths of the study
Selection bias is likely to have been 
minimised in this study by the high target 
group coverage achieved consistently across 
screen locations. 
Implications
This study has significant implications. 
The age selected to commence screening 
Indigenous Australian adults for chronic 
disease risk has until now relied on expert 
opinion. Our findings should inform future 
recommendations regarding age of screening 
onset in remote Aboriginal and Torres Strait 
Islander populations in far north Queensland, 
and potentially, more broadly across remote 
Australia. Screening programs should be 
appropriately linked then with management 
and treatment programs that engage young 
people. At a population level, the prevalence 
of pre-hypertension alone suggests a need 
for widespread environmental and policy 
action that supports antenatal and early 
childhood development and promotes a 
healthy lifestyle across the life course. 
The heterogenous distribution of risk factors 
indicated demonstrates that targeted 
chronic disease screening, for example, 
Esler et al.
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directed only at overweight or obese young 
adults, is not appropriate. The significant 
association between overweight, obesity and 
hypertension emphasises the need to address 
the obesogenic environment in which remote 
Indigenous youth live. 
The finding of a greater burden of 
hypertension and pre-hypertension among 
males is not explained and requires further 
investigation and specific preventive action. 
It may be that the prevalence of other risk 
factors not assessed in the YPC, such as 
cigarette smoking and alcohol intake, may 
contribute to this differential. 
Conclusion
The prevalence of overweight and obesity, 
pre-hypertension, hypertension and impaired 
renal function observed in this study suggest 
that many remote-living Indigenous young 
adults are already on a trajectory towards 
diabetes and cardiovascular diseases. 
Preventive health action that aims to address 
the burden of cardiovascular disease in 
Indigenous communities must have an 
impact prior to adolescence to prevent the 
development of risk factors already clearly 
apparent in Indigenous young people. As 
well as primary prevention, the detection of 
chronic disease risk among Indigenous youth 
and management of individuals found to be 
at risk must take priority.
Although there are some differences in 
the prevalence of specific risk factors 
among Aboriginal and Torres Strait Islander 
participants (such as the statistically 
significant difference in the prevalence of 
hypertension across genders), the unifying 
theme of high chronic disease risk factor 
prevalence supports a screening program 
directed at all Indigenous youth. Within 
resource constraints, chronic disease 
risk factor screening for both Aboriginal 
and Torres Strait Islander people should 
commence early, by age 15 years at the latest. 
Within an international context, this study 
highlights the importance of exploring the 
hypertension and cardiovascular disease risk 
experienced by disadvantaged subgroups 
living within developed nations, in particular 
Indigenous populations.
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